
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
SYSTEMATIC REVIEW article
Front. Med.
Sec. Gastroenterology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1541461
This article is part of the Research Topic Advances in Medical Imaging for Precision Diagnostic and Therapeutic Applications in Digestive Diseases View all articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose: This meta-analysis aimed to compare the diagnostic effectiveness of [ 68 Ga]Ga-FAPI-04 PET and [ 18 F]FDG PET for detecting lymph node metastasis in digestive system cancer patients.A comprehensive search of PubMed, Web of Science, and Embase databases was conducted to identify relevant articles up to June 2024. Studies were included if they evaluated the diagnostic performance of [ 68 Ga]Ga-FAPI-04 PET and [ 18 F]FDG PET in detecting lymph node metastasis in digestive system cancer patients. Sensitivity and specificity were assessed using the DerSimonian and Laird method and were transformed using the Freeman-Tukey double arcsine transformation.Results: 15 articles, encompassing a total of 617 patients, were included in this study. The overall sensitivity of [ 68 Ga]Ga-FAPI-04 PET for diagnosing lymph node metastasis in digestive system cancers was 0.82 (95% CI: 0.67-0.93), and the specificity was 0.91 (95% CI: 0.84-0.97). In comparison, the sensitivity of [ 18 F]FDG PET was 0.51 (95% CI: 0.38-0.63), with a specificity of 0.81 (95% CI: 0.64-0.94). These results suggest that [ 68 Ga]Ga-FAPI-04 PET has a significantly higher sensitivity (P < 0.01) and similar specificity (P = 0.20) compared to [ 18 F]FDG PET in detecting lymph node metastasis in digestive system cancers.Our meta-analysis indicates that [ 68 Ga]Ga-FAPI-04 PET has higher sensitivity and similar specificity compared to [ 18 F]FDG PET in diagnosing lymph node metastasis in 3 digestive system cancers. However, the high heterogeneity among the studies may impact the robustness of the current evidence. Therefore, future research should prioritize larger prospective studies with more diverse populations and specific cancer subtypes to draw more definitive conclusions.
Keywords: Digestive system cancers, [ 68 Ga]Ga-FAPI-04 PET, [ 18 F]FDG PET, lymph node metastasis, Meta-analysis
Received: 07 Dec 2024; Accepted: 05 Mar 2025.
Copyright: © 2025 Li, Li, Qin, Huang, Qin, Chen and Ouyang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rong Ouyang, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi Zhuang Region, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.